Solasto Corporation provides medical outsourcing services to medical institutions in Japan. It operates through the Medical Business, Nursing Care Business, Children's Business, and Others segments. The Medical Business segment offers medical administration, medical affairs, and hospital management support services, as well as various surveys and analyses in the fields of medical administration and hospital management, document preparation, lectures and training, and educational courses on medical administration services. Its Nursing Care Business segment provides nursing care services, including nursing homes, residential nursing homes, and serviced housing for the elderly, as well as day care and home help services. The Children's Business segment offers childcare services, such as licensed, certified, and small-scale childcare centers, as well as childcare centers for recovering children. Its Others segment operates its smart hospital business that provides remote medical fee billing services to medical institutions. Solasto Corporation was formerly known as N.I.C Corporation. The company was founded in 1965 and is headquartered in Tokyo, Japan. As of May 11, 2026, Solasto Corporation operates as a subsidiary of MP-2605 Co., Ltd.
Solasto (6197) announced a board resolution on 2026-05-27 to cancel all treasury shares held as of the cancellation date…
Summary
Solasto (6197) announced a board resolution on 2026-05-27 to cancel all treasury shares held as of the cancellation date (2026-08-07), totaling approximately 4.19 million shares or 4.43% of issued shares. The cancellation is conditional upon shareholder approval of a concurrent stock consolidation at an extraordinary general meeting scheduled for 2026-07-06, with the cancellation becoming effective 2026-08-10.
Deadline: 2026-08-07% of Shares: 4.4%Shares: 4,191,218
MP-2605株式会社 completed a public tender offer for all ordinary shares of Solasto (code 6197) that ended on May 11, 2026. T…
Summary
MP-2605株式会社 completed a public tender offer for all ordinary shares of Solasto (code 6197) that ended on May 11, 2026. The bidder acquired 48,373,328 shares at ¥1,119 per share, representing 53.42% of voting rights, thereby becoming the parent company and majority shareholder. Following settlement on May 18, 2026, the company is expected to be delisted from Tokyo Stock Exchange Prime Market as part of a two-stage acquisition process.
Deadline: 2026-05-11% of Shares: 53.4%Shares: 48,373,328